Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

Ítems similars

• An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
  per: Jin, X., et al.
  Publicat: (2000)
• Levels of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Effector and Memory Responses Decline after Suppression of Viremia with Highly Active Antiretroviral Therapy
  per: Kalams, Spyros A., et al.
  Publicat: (1999)
• Rapid Viral Decay in Simian Immunodeficiency Virus-Infected Macaques Receiving Quadruple Antiretroviral Therapy
  per: Brandin, Eleonor, et al.
  Publicat: (2006)
• Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1
  per: Dyer, Wayne B., et al.
  Publicat: (1999)
• Human Immunodeficiency Virus Type 1- and Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Persist at High Frequency for Prolonged Periods in the Absence of Circulating Peripheral CD4(+) T Cells
  per: Spiegel, Hans M. L., et al.
  Publicat: (2000)